Medicare Enrolled

Dr. Robert Ikeman, MD

Rheumatology · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1945 VERSAILLES ST, Sarasota, FL 34239
9413650770
In practice since 2005 (20 years)
NPI: 1407831498 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ikeman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ikeman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ikeman

Dr. Robert Ikeman is a rheumatology in Sarasota, FL, with 20 years in practice. Based on federal Medicare data, Dr. Ikeman performed 126,665 Medicare services across 1,625 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ikeman received a total of $21,443 from 41 pharmaceutical and/or device companies across 1010 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ikeman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 19% volume in FL$ $21,443 industry payments

Medicare Practice Summary

Medicare Utilization ↗
126,665
Medicare services
Top 19% in FL for rheumatology
1,625
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,333 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)45,800$4$20
Tocilizumab injection (Actemra)23,871$5$10
Golimumab infusion (Simponi Aria)21,001$11$50
Abatacept infusion (Orencia)15,300$34$100
Romosozumab injection (Evenity) for osteoporosis9,240$8$12
Denosumab injection (Prolia/Xgeva)6,364$18$28
Infliximab infusion (Remicade)2,412$26$110
Office visit, established patient (30-39 min)1,214$92$289
Drug injection, under skin or into muscle386$11$30
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less344$50$100
Administration of chemotherapy into vein, 1 hour or less130$101$550
New patient office visit (45-59 min)106$127$350
Office visit, established patient (20-29 min)85$64$200
Joint injection, major joint72$48$160
Injection, zoledronic acid, 1 mg70$7$50
Injection, methylprednisolone acetate, 40 mg69$6$14
Injection, methylprednisolone acetate, 80 mg62$9$38
Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment54$50$125
Administration of chemotherapy into vein, each additional hour46$22$150
Injection of additional new drug or substance into vein20$12$34
New patient office visit, complex (60-74 min)19$157$375
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.8% high complexity
68.0% medium
1.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$21,443
Total received (2018-2024)
Avg $3,063/year across 7 years
Top 21% in FL for rheumatology
41
Companies
1,010
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,443 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,757
2023
$3,270
2022
$2,383
2021
$1,873
2020
$2,144
2019
$4,207
2018
$4,809

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,131
Novartis Pharmaceuticals Corporation
$2,311
PFIZER INC.
$2,195
ABBVIE INC.
$1,491
AbbVie, Inc.
$1,319
Lilly USA, LLC
$1,206
GlaxoSmithKline, LLC.
$1,006
UCB, Inc.
$925
AbbVie Inc.
$910
E.R. Squibb & Sons, L.L.C.
$852
Janssen Biotech, Inc.
$836
AstraZeneca Pharmaceuticals LP
$769
Genentech USA, Inc.
$608
Radius Health, Inc.
$603
Horizon Therapeutics plc
$534
GENZYME CORPORATION
$526
Boehringer Ingelheim Pharmaceuticals, Inc.
$485
Celgene Corporation
$274
Janssen Scientific Affairs, LLC
$269
Aurinia Pharma U.S., Inc.
$135
Fidia Pharma USA Inc.
$108
Mallinckrodt Hospital Products Inc.
$101
Horizon Pharma plc
$98
Actelion Pharmaceuticals US, Inc.
$95
Flexion Therapeutics, Inc.
$87
Sobi, Inc
$81
Kiniksa Pharmaceuticals, Ltd.
$66
Alexion Pharmaceuticals, Inc.
$64
Kiniksa Pharmaceuticals International, plc
$56
Mallinckrodt Enterprises LLC
$47
Mallinckrodt LLC
$46
Mylan Institutional Inc.
$33
SOBI, INC
$30
Fresenius Kabi USA, LLC
$26
Pacira Therapeutics, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$20
Oxford Immunotec USA Inc
$19
Almatica Pharma LLC
$18
Ultragenyx Pharmaceutical Inc.
$15
FIDIA PHARMA USA INC.
$13
Ironwood Pharmaceuticals, Inc
$13
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · DUZALLO · EVENITY · EVUSHELD · Enbrel · FORTEO · HUMIRA · HYMOVIS · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Prolia · RAYOS · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · TSPOT TB TEST · Tavneos · Tymlos · Uloric · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $17 per 100 Medicare services performed
Looking for a rheumatology in Sarasota?
Compare rheumatologys in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
25
Per 100K population
5.6
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ikeman is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ikeman experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Ikeman performed 45,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ikeman receive payments from pharmaceutical companies?
Yes. Dr. Ikeman received a total of $21,443 from 41 companies across 1,010 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ikeman's costs compare to other rheumatologys in Sarasota?
Dr. Ikeman's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ikeman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →